UK pins hopes on ozone in TSE (transmissible spongiform encephalopathies) sterilisation battle
This article was originally published in Clinica
A reliable sterilisation method for devices used in surgery deemed to pose a significant risk of infection from transmissible spongiform encephalopathies continues to elude UK healthcare policy makers, but a promising ozone-based system is about to be put to the test.
You may also be interested in...
ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage.
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.